Characterization of the Sleep-Wake Cycle in Traumatic Brain Injury Patients with a Disorder of Consciousness (SLEEPDOC)

January 8, 2025 updated by: Hospices Civils de Lyon
Each year in France, 160,000 peoples suffer from a mild or severe traumatic brain injury (TBI). Sleep plays a crucial role in the process of brain plasticity, which is essential for neurological and cognitive recovery. However, the sleep-wake cycle is rarely, if ever, evaluated in patients with TBI and consciousness disorders within Post-Resuscitation Rehabilitation Units (SRPR). Caregivers develop, on a daily basis, an intuitive understanding of the patient's overall condition. This expertise deserves to be validated using objective sleep assessment tools (actigraphy). If proven accurate, it could lead to the implementation of a sleep-wake cycle evaluation protocol within SRPRs.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bron, France, France, 69500
        • Hôpital Neurologique Pierre Wertheimer, Service de Réanimation Polyvalente Neurologique
        • Contact:
        • Contact:
          • Jacques LUAUTE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Admission to the Post-Resuscitation Rehabilitation Unit or the Neurological Intensive Care Unit
  • Consciousness disorders: Vegetative State or Minimally Conscious State (according to the CRS-R)
  • Traumatic brain injury
  • Patient aged 18 years or older
  • Presence of relatives able to express non-opposition to the study
  • Subjects affiliated with a social security scheme (or beneficiaries)

Exclusion Criteria:

  • Admission for status epilepticus
  • Individuals admitted to a healthcare or social care facility for purposes other than research
  • Adults under legal protection measures (guardianship, conservatorship)
  • Individuals not affiliated with a social security scheme or not benefiting from a similar scheme

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients in a vegetative state
actimetry will be performed continuously during these 104 hours.
The subjective assessments of the patient's awake/sleep state will be collected every 2 hours during the night and at least 3 times during the day, for a total of at least 8 assessments per 24-hour period, over a duration of 104 consecutive hours (slightly more than 4 days, starting at midnight and ending at 8 :00 AM, to cover 4 full days and 4 full nights).
MOCA : Montreal Cognitive Assessment
SF-36 The Short Form (36)
CRS-R (Coma Recovery Scale-Revised)
GOSE (Glasgow Outcome Scale-Extended)
GCS (Glasgow Coma Scale)
Experimental: Patients in a minimally conscious state
actimetry will be performed continuously during these 104 hours.
The subjective assessments of the patient's awake/sleep state will be collected every 2 hours during the night and at least 3 times during the day, for a total of at least 8 assessments per 24-hour period, over a duration of 104 consecutive hours (slightly more than 4 days, starting at midnight and ending at 8 :00 AM, to cover 4 full days and 4 full nights).
MOCA : Montreal Cognitive Assessment
SF-36 The Short Form (36)
CRS-R (Coma Recovery Scale-Revised)
GOSE (Glasgow Outcome Scale-Extended)
GCS (Glasgow Coma Scale)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Subjective assessments
Time Frame: during 104 consecutive hours after enrollment
during 104 consecutive hours after enrollment
Actimetry
Time Frame: during 104 consecutive hours after enrollment
during 104 consecutive hours after enrollment

Secondary Outcome Measures

Outcome Measure
Time Frame
Coma Recovery Scale-Revised
Time Frame: once a day for 6 to 5 days
once a day for 6 to 5 days
Coma Recovery Scale-Revised
Time Frame: 3 months after the start of study
3 months after the start of study
Coma Recovery Scale-Revised
Time Frame: 6 months after the start of study
6 months after the start of study
Glasgow Coma Scale assessment
Time Frame: once a day for 6 to 5 days
once a day for 6 to 5 days
Glasgow Coma Scale assessment
Time Frame: 3 months after the start of study
3 months after the start of study
Glasgow Coma Scale assessment
Time Frame: 6 months after the start of study
6 months after the start of study
Glasgow Outcome Scale-Extended assessment
Time Frame: 6 months after the start of study
6 months after the start of study
Glasgow Outcome Scale-Extended assessment
Time Frame: 3 months after the start of study
3 months after the start of study
Montreal Cognitive Assessment
Time Frame: 3 months after the start of study
3 months after the start of study
Montreal Cognitive Assessment
Time Frame: 6 months after the start of study
6 months after the start of study
Short Form 36 assessment
Time Frame: 3 months after the start of the study
3 months after the start of the study
Short Form 36 assessment
Time Frame: 6 months after the start of study
6 months after the start of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacques LUAUTE, Professor, Hôpital Neurologique Pierre Wertheimer, Service de Service de Rééducation Post-Réanimation
  • Principal Investigator: Florent GOBERT, Doctor, Hôpital Neurologique Pierre Wertheimer, Service de Réanimation Polyvalente Neurologique

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2025

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

August 1, 2028

Study Registration Dates

First Submitted

December 16, 2024

First Submitted That Met QC Criteria

January 8, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 8, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma, Nervous System

Clinical Trials on Actimetry

Subscribe